In this Issue
Current Practices and Next-Generation Technologies
CHIEF MEDICAL EDITORS' PAGE
By Ted E. Feldman, MD, MSCAI, FACC, FESC; and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC
Understanding STS score, EuroSCORE, and frailty indices.
By Troels Højsgaard Jørgensen, MD; and Lars Søndergaard, MD, DMSc
An expert opinion on how current clinical trials will impact the future of TAVI procedures in low-risk patients.
With Marc Dweck, MD, PhD
An update on where TAVR is going as the technology matures in the United States.
By John C. Messenger, MD
Current application of TAVI in Europe.
By Giuliano Costa, MD; Marco Barbanti, MD; and Corrado Tamburino, MD, PhD
Emerging valve systems and iterative technologies from around the world and how they could shape global practice going forward.
By Federico Mercanti, MD; Zhen-Gang Zhao, MD; Antoinette Neylon, MD, BCh; Mao Chen, MD, PhD; and Darren Mylotte, MD, BCh
A collection of ongoing and completed trials investigating TAVR procedures and devices. Our trial charts allow for comparison of multiple trials across many categories and are updated throughout the year as industry provides data.
FEATURED TECHNOLOGYSponsored by BioTrace Medical Inc.
The Tempo® Lead from BioTrace Medical Inc. delivers safe lead placement, secure pace capture, and postprocedure ambulation.
A review of diagnosis and principles of percutaneous mechanical circulatory support to optimize RV preload, afterload, and contractility after acute RV failure.
By Ivan D. Hanson, MD; and James A. Goldstein, MD
An important and effective noninvasive test for evaluating ischemia without the need for additional testing or radiation exposure.
By Jonathon Leipsic, MD, FRCPC; Stephanie Sellers, PhD; and Frederick St. Goar, MD
A patient-centered debate on the safety, efficacy, and durability of transcatheter aortic valve replacement versus surgical aortic valve replacement for intermediate-risk patients.
With Bruce Rutkin, MD; S. Jacob Scheinerman, MD, FACS; and Issam D. Moussa, MD, MBA
CODING & REIMBURSEMENT
The High-Performing Cardiovascular Service Line: Evolving Leadership and Governance in the Value Economy
How to create an intentional, carefully designed clinical strategy that establishes expected outcomes for care and creates standards for care delivery.
By Ginger Biesbrock, PA-C, MPH, MPAS, AACC; and Joel Sauer, MBA
Dr. Vahanian shares his thoughts on the updated ESC/EACTS guidelines and the ongoing evolution of valvular intervention.